Growth Metrics

CVRx (CVRX) EBITDA Margin (2020 - 2026)

CVRx's quarterly EBITDA Margin came in at 88.83% in Q1 2026, up 2265.0% year-on-year from 3.76% in Q1 2025, and down 19.28% quarter-over-quarter from 74.48% in Q4 2025.

CVRx has reported EBITDA Margin for 7 years, with the latest figure at 88.83% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 2265.0% year-over-year to 88.83%; the trailing twelve-month figure through Mar 2026 stood at 89.14% (up 834.0% YoY), and the FY2025 full-year result was 94.09%, up 2282.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 88.83%, down from 74.48% in the prior quarter.
  • The five-year high for EBITDA Margin was 69.41% in Q4 2024, with the low at 245.26% in Q1 2022.
  • Average EBITDA Margin over 5 years is 127.42%, with a median of 111.48% recorded in 2025.
  • Year-over-year, EBITDA Margin jumped 34814 bps in 2022 and sank 6351 bps in 2024.
  • Tracing CVRX's EBITDA Margin over 5 years: stood at 146.66% in 2022, then soared by 45 bps to 81.04% in 2023, then grew by 14 bps to 69.41% in 2024, then declined by 7 bps to 74.48% in 2025, then slipped by 19 bps to 88.83% in 2026.
  • The last three EBITDA Margin figures came in at 88.83% (Q1 2026), 74.48% (Q4 2025), and 87.62% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 CVRx 144.43 Mn 72.13 Mn 12.88 Mn -88.83%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -88.83%
Dec 31, 2025 -74.48%
Sep 30, 2025 -87.62%
Jun 30, 2025 -108.42%
Mar 31, 2025 -111.48%
Dec 31, 2024 -69.41%
Sep 30, 2024 -97.94%
Jun 30, 2024 -118.82%
Mar 31, 2024 -206.03%
Dec 31, 2023 -81.04%
Sep 30, 2023 -85.93%
Jun 30, 2023 -122.46%
Mar 31, 2023 -142.51%
Dec 31, 2022 -146.66%
Sep 30, 2022 -159.04%
Jun 30, 2022 -220.19%
Mar 31, 2022 -245.26%
Dec 31, 2021 -288.96%
Sep 30, 2021 -180.74%
Jun 30, 2021 -568.33%
Mar 31, 2021 -301.78%
Dec 31, 2020 -162.64%
Sep 30, 2020 -322.27%
Jun 30, 2020 -294.24%